Name | Palazestrant |
---|
Description | Palazestrant is an antiestrogen and antineoplastic agent. Palazestrant in combination with a HER2 inhibitor, works on ER+/HER2+ cancer[1][2]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C28H36FN3O |
---|---|
Molecular Weight | 449.60 |